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Abstract
Introduction: Preanalytical specifications for urinalysis must be strictly adhered to avoid false interpretations. Aim of the present study is to exami-
ne whether the preanalytical factor ‘time point of analysis’ significantly influences stability of urine samples for urine particle and dipstick analysis.
Materials and methods: In 321 pathological spontaneous urine samples, urine dipstick (Urisys™2400, Combur-10-Test™strips, Roche Diagnostics, 
Mannheim, Germany) and particle analysis (UF-1000 i™, Sysmex, Norderstedt, Germany) were performed within 90 min, 120 min and 240 min after 
urine collection.
Results: For urine particle analysis, a significant increase in conductivity (120 vs. 90 min: P < 0.001, 240 vs. 90 min: P < 0.001) and a significant 
decrease in WBC (120 vs. 90 min P < 0.001, 240 vs. 90 min P < 0.001), RBC (120 vs. 90 min P < 0.001, 240 vs. 90 min P < 0.001), casts (120 vs. 90 min 
P < 0.001, 240 vs. 90 min P < 0.001) and epithelial cells (120 vs. 90 min P = 0.610, 240 vs. 90 min P = 0.041) were found. There were no significant 
changes for bacteria. Regarding urine dipstick analysis, misclassification rates between measurements were significant for pH (120 vs. 90 min P < 
0.001, 240 vs. 90 min P < 0.001), leukocytes (120 vs. 90 min P < 0.001, 240 vs. 90 min P < 0.001), nitrite (120 vs. 90 min P < 0.001, 240 vs. 90 min P 
< 0.001), protein (120 vs. 90 min P < 0.001, 240 vs. 90 min P<0.001), ketone (120 vs. 90 min P < 0.001, 240 vs. 90 min P < 0.001), blood (120 vs. 90 
min P < 0.001, 240 vs. 90 min P < 0.001), specific gravity (120 vs. 90 min P < 0.001, 240 vs. 90 min P < 0.001) and urobilinogen (120 vs. 90 min, P = 
0.031). Misclassification rates were not significant for glucose and bilirubin. 
Conclusion: Most parameters critically depend on the time window between sampling and analysis. Our study stresses the importance of adheren-
ce to early time points in urinalysis (within 90 min).
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Introduction
Urinalysis with urine dipsticks and urine particle 
analysis are established methods in the daily rou-
tine of diagnosis and control of urinary tract infec-
tions (UTI) in hospital laboratories as well as outpa-
tient departments. Various types of indication for 
urinalysis exist, including diagnosis, disease moni-
toring, screening, check-up, and therapy control in 
infections, bleedings and diseases of the kidneys 
and the urinary tract, metabolic disorders (e.g. dia-
betes mellitus), liver and hematological diseases 
(1). Aiming for continuous improvement in diagno-
sis, automated urinalysis was established and has 
now become part of standard examinations (2,3). 
Studies comparing urine particle counts by urine 
flow cytometry using UF 1000i™ (Sysmex, Norder-
stedt, Germany) and bacterial culture showed a 
good correlation and in part a better performance 
(4,5). However, the current stage of objectivity and 
standardization cannot prevent potential sources 
of error in preanalytics. In view of the fact that UTIs 
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are among the most common infections world-
wide, preanalytical errors can have a far-reaching 
impact (6). In the US, more than seven million cas-
es of urinary tract infections are seen by physicians 
every year (7). The European Guidelines for Urinal-
ysis list urine dipstick analysis and microscopy as 
alternative diagnostic tools in uncomplicated cys-
titis and recommend antibiotic therapy in line with 
an existing concomitant disease (8). Correct urinal-
ysis results are especially important for distin-
guishing between physiological and pathological 
cell numbers. Further diagnostic approaches as 
well as any clinical decision for or against therapy 
are based on this analysis. Consequently, false re-
sults in urinalysis cause a high risk of incorrect 
over- or undertreatment. 
The European Guidelines for Urinalysis were first 
published in 2000 (8). Since more than 50% of all 
faulty laboratory results are preanalytical, the uri-
nanalysis guidelines provide clear instructions for 
urinalysis, especially regarding time of analysis 
and correct adherence to standardized preanalyti-
cal procedures (9). To ensure correct analysis, the 
current version of the CLSI Guidelines from 2009 
provides important information on different types 
of urine specimens, detailed descriptions regard-
ing definition of first morning urine specimen and 
collection of clean catch specimens from male and 
female patients. Also, details on transport and 
storage in relation to urinalysis preanalytics are 
provided. Regarding specimen acceptability, the 
CLSI Guidelines recommend urinalysis within two 
hours from sampling. If this is not possible, sam-
ples should be stored immediately at 4 °C. Further 
analyses should be performed within four hours 
(1). Urine cultures can be analyzed at 4 °C for a pe-
riod of 24 hours (h) (10). One study analyzing urine 
samples, which were stored for 2h and 4h at room 
temperature without addition of preservatives, 
found no significant differences when comparing 
the results (11). The reference ranges for urine pa-
rameters are problematic (12). Some threshold val-
ues reported in the literature are inconsistent. For 
example, for UF-100™ (Sysmex, Norderstedt, Ger-
many) in a collective of 1005 samples, the cut-off 
value for leucocytes (WBC) was given as 111 WBC / 
µL and for bacteria, 3000 bacteria / µL. While for 
WBC, this was within the reference range as rec-
ommended by the manufacturer, the cut-off value 
for bacteria as recommended by the manufacturer 
was in fact 8000 bacteria / µL (13). Another critical 
aspect in urinalysis is the time interval of sample 
analysis after collection. During sample storage, 
the preanalytical focus must not only be on cor-
rect storage, but also on sample stability (14). 
It remains unclear, however, on what data the rec-
ommendations regarding time for analysis are 
based on. Limited information is available regard-
ing behaviour and/or changes in urinalysis/meas-
urement results from early analysis times (11). As 
this may have immediate consequences for the 
patients, it remains to be investigated whether 
there is in fact a critical time period within which 
urinalysis must be performed. Therefore, the aim 
of the present study was to examine whether the 
preanalytical factor ‘time point of analysis’ signifi-
cantly influences stability of urine samples in urine 
particle analysis and urine dipstick analysis. 
Materials and methods
Materials
In our study, we analyzed 321 pathological urine 
samples (spontaneous urine, mid stream, clean 
catch specimens) collected over a period of two 
months. Samples were collected in 10 mL Urine 
Monovettes (Sarstedt, Nümbrecht, Germany) with-
out bacteria growth inhibitors and analyzed im-
mediately after collection. 
All samples were urine samples from the routine 
collective of the central laboratory at the Universi-
ty Clinics Bonn, Germany (collected at the wards 
and outpatient departments of the University Clin-
ics Bonn, Germany) as part of clinical examina-
tions. All samples had to fulfil one of the following 
inclusion criteria at the first measurement: eryth-
rocytes > 20 / µL, leucocytes > 20 / µL, bacteria > 
100 / µL, dipstick positive for blood/leucocytes/ni-
trite. Samples from pediatric patients were exclud-
ed. To assure the performance of the first analysis 
within 90 min, sample arrival was monitored in co-
operation with the wards and outpatient depart-
ments’ staff. Urine samples were stored in capped 
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containers at room temperature between analy-
ses.
Methods
Urine dipstick measurements were performed 
with Urisys™ 2400 (Roche Diagnostics GmbH, Man-
nheim, Germany) using Combur10Test™ strips. This 
analyzer uses the following measurement meth-
ods: reflectance photometry (wave lengths 470 
nm, 555 nm, 620 nm; refractometry (density), tur-
bidimetry (cloudiness)). Urine particle analysis was 
performed with UF-1000i™ (Sysmex, Norderstedt, 
Germany) as quantitative and semi-quantitative 
analysis. This instrument uses the following meas-
urement methods: fluorescence flow cytometry 
with diode laser and hydrodynamic focusing and 
conductometry. The reference ranges were as rec-
ommended by the respective manufacturers. 
Measurements were done within 90 min, 120 min 
and 240 min from sample collection. The measure-
ment time point of 90 min was chosen since it rep-
resents a feasible preanalytical time period in our 
daily routine.
Prior to each measurement, the urine was mixed 
automatically as well as manually. First, urine dip-
stick analysis was performed for the following pa-
rameters: specific weight, pH, leucocytes, erythro-
cytes, nitrite, protein, glucose, ketone, urobilino-
gen, bilirubin. Next, automated urine particle anal-
ysis was performed for the following parameters: 
conductivity, white blood cell count (WBC), red 
blood cell count (RBC), epithelial cells (EC), bacteria 
(bac) and casts. For each measurement, 4 mL of 
urine were used. 
Statistical analysis
Data were statistically analyzed using the IBM SPSS 
Statistics, Version 20 (IBM Corporation, New York, 
United States). The Kolmogorov-Smirnov, Fried-
man test and McNemar ś tests for paired samples 
were used. P < 0.05 was considered statistically 
significant: Variables of urine particle analysis were 
described by median and interquartile range (IQR). 
For urine dipstick parameters, misclassification 
rates were analyzed. Normality of distribution was 
tested by Kolmogorov-Smirnov tests for all varia-
bles. All parameters were non-normally distribut-
ed. Continuous data were tested by nonparamet-
ric tests for repeated measures (Friedman tests). 
Categorical data were examined by McNemar ś 
tests for paired samples. Categorical data in cate-
gories where frequencies were low (< 5) were 




The particle analysis parameters investigated are 
shown in Table 1. A significant increase in conduc-
tivity at 120 min and 240 min after urine collection 
was noted (conductivity 120 vs. 90 min: P < 0.001, 
240 vs. 90 min: P < 0.001). Regarding WBC, RBC and 
casts, a significant decrease in cell numbers was 
found at 120 min and 240 min after urine collec-
tion (WBC 120 vs. 90 min P < 0.001, 240 vs. 90 min P 
< 0.001; RBC 120 vs. 90 min P < 0.001, 240 vs. 90 
min P < 0.001; casts 120 vs. 90 min P < 0.001, 240 vs. 
90 min P < 0.001). There were no significant chang-
es for bacteria (bac 120 vs. 90 min P = 0.283, 240 vs. 
90 min P = 0.194). 
Urine dipstick analysis
Statistical data for the parameters analyzed are 
shown in Table 2. Misclassification rates between 
the different time intervals (120 vs. 90 min, 240 vs. 
90 min) were significant for pH (120 vs. 90 min P < 
0.001, 240 vs. 90 min P < 0.001), leukocytes (120 vs. 
90 min P < 0.001, 240 vs. 90 min P < 0.001), nitrite 
(120 vs. 90 min P < 0.001, 240 vs. 90 min P < 0.001), 
protein (120 vs. 90 min P < 0.001, 240 vs. 90 min P < 
0.001), ketones (120 vs. 90 min P < 0.001, 240 vs. 90 
min P < 0.001), blood (120 vs. 90 min P < 0.001, 240 
vs. 90 min P < 0.001), specific gravity (120 vs. 90 
min P < 0.001, 240 vs. 90 min P < 0.001) and uro-
bilinogen (120 vs. 90 min P = 0.031, 240 vs. 90 min P 
= 0.125). Misclassification rates were not significant 
for glucose and bilirubin (glucose 120 vs. 90 min P 
= 0.250, 240 vs. 90 min P = 1.000; bilirubin 120 vs. 
90 min P = 1.000, 240 vs. 90 min P = 0.125). 
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Parameter 
(N = 321) T0 T1 T2
P
(T0 vs . T1)
P
(T0 vs . T2)




(11.9 – 19.1) P < 0.001 P < 0.001




(20 – 306) P < 0.001 P < 0.001
RBC (/µL) 39 (14 – 267) 35 (11 – 211) 27 (9 – 193) P < 0.001 P < 0.001
Epithelial cells (/µL) 11 (5 – 22) 11 (5 – 21) 11 (4 – 23) P = 0.610 P = 0.041




(19 – 1949) P = 0.283 P = 0.194
Casts (/µL) 1 (0 – 2) 1 (0 – 2) 1 (0 – 2) P = 0.009 P < 0.001
Data are presented as median and interquartile range (IQR). The Friedman test was used to test the differences in urine particle 
analysis for urine particles analysed in the respective analysis time points: T0 - within 90 min, T1 - 120 min after collection and T2 - 
240 min after collection. WBC - white blood cell count. RBC - red blood cell count. P < 0.05 was considered statistically significant.
*N = 309 (12 samples missing).
†N = 320 (1 sample missing).
Table 1. Urine particle analysis parameters in three different time points.
Parameter 
(N = 321) T0 vs . T1 T0 vs . T2
P
(T0 vs . T1)
P
(T0 vs . T2)
pH 27 (8.4) 33 (10.3) P < 0.001 P < 0.001
Leukocytes (/µL) 45 (14.0) 31 (9.7) P < 0.001 P < 0.001
Nitrite (pos/neg) 12 (3.7) 17 (5.3) P < 0.001 P < 0.001
Protein (mg/dL) 22 (6.9) 30 (9.3) P < 0.001 P < 0.001
Glucose (mg/dL) 1 (0.3) 3 (0.9) P = 0.250 P = 1.000
Ketone (mg/dL) 29 (9.0) 28 (8.7) P < 0.001 P < 0.001
Urobilinogen (mg/dL) 6 (1.9) 4 (1.2) P = 0.031 P = 0.125
Bilirubin (mg/dL) 1 (0.3) 4 (1.2) P = 1.000 P = 0.125
Blood (/µL) 37 (11.5) 64 (19.9) P < 0.001 P < 0.001
Specific gravity 35 (10.9) 57 (17.8) P < 0.001 P < 0.001
Shown are misclassification rates (absolute numbers and percent (in brackets)) and P values (McNemars’ tests) for urine dipstick 
analysis parameters pH, leukocytes, nitrite, protein, glucose, ketone, urobilinogen, bilirubin, blood and specific gravity for the 
respective time points (T0 - within 90 min, T1 - 120 min after collection, T2 - 240 min after collection, T0 vs. T1 - within 90 min in 
comparison to 120 min after collection, T0 vs. T2 within 90 min in comparison to 240 min after collection).
Table 2. Misclassification rates for urine dipstick analysis.
Discussion
The present study shows that significant changes 
occur during automated urine particle analysis of 
the parameters WBC, RBC, casts and conductivity 
over the course of the respective time points of 
measurement. A significant decrease in concentra-
tions of RBC, WBC as well as casts can already be 
noted between 90 and 120 min. A significant in-
crease in conductivity was found over the course 
of the respective time points of measurement. In 
automated urine particle analysis no significant 
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changes were noted regarding bacteria. In some 
patients, we detected a decrease in bacteria popu-
lations, while in others, we found an increase. For 
the following parameters of the urine dipstick 
analysis, significant misclassifications over time 
were found: specific gravity, pH values, leucocytes, 
blood, nitrite, ketones, protein and urobilinogen 
(only at 120 min after collection). No significant 
changes were found for glucose and bilirubin. In 
line with results from automated urine particle 
analysis, both measurement methods showed a 
decrease in WBC and RBC; significant misclassifica-
tions were also found for blood and leucocytes in 
urine dipstick analysis. For clinical assessment, it 
has to be noted that the protein pad of the urine 
dipstick analysis detects mainly urine albumin. The 
CLSI Guidelines state that optimum analysis is only 
possible with adequately collected analysis mate-
rial that has been correctly transported to the lab-
oratory. The guidelines claim that, while urinalysis 
should be performed as rapidly as possible, analy-
sis can be done up to two hours after sample col-
lection during which time the sample is stored at 
room temperature (1). Our results show that al-
ready at a time shorter than 120 min from urine 
collection, differences are detectable in the indi-
vidual measurement results. The question arises 
whether this is clinically relevant. In urine particle 
count, the combination of leukocyturia and eryth-
rocyturia is generally used to confirm the diagno-
sis of urinary tract infection, while in urine dipstick 
analysis diagnosis is confirmed by positive leuko-
cyte and blood test pads (15). In contrast to earlier 
studies with UF100™ (Sysmex), where RBCs were 
not significantly decreased after up to three days 
storage at room temperature without preserva-
tives, the present study reveals a significant de-
crease in this parameter over time (16). Thus, a po-
tentially false negative finding can occur when 
analysis is delayed. The inability of exact WBC clas-
sification can cause problems in clinical interpreta-
tion. Depending on the tentative diagnosis, exact 
classification in neutrophil granulocytes (bacterial 
infections) (17), eosinophil granulocytes (e.g. acute 
interstitial nephritis) (18) or lymphocytes (e.g. 
transplant rejection) would be beneficial (19). 
Urine dipstick analysis reveals ester activity of 
granulocytes. Here, the label ‘leukocyte’ for the re-
spective test pad may be misleading for the clini-
cian, since it only refers to neutrophil granulo-
cytes. Incorrect interpretations of the obtained 
test findings at a later point in time may not only 
result in undertreatment but may also lead to in-
creased costs of analysis due to implausible re-
sults. In the US, the annual cost of antibiotic treat-
ment of UTI is estimated to be above one billion 
dollars (20). Based on our results, we recommend 
that urinalysis is not only performed as rapidly as 
possible according to CLSI Guidelines, but opti-
mally within 90 min from sample collection. The 
time point of 90 min was chosen as it represents a 
feasible time period in the current daily routine of 
sample collection and transport between the vari-
ous wards and outpatient departments and the 
central laboratory at the University Clinics Bonn, 
Germany. At the University Clinics’ Bonn central 
laboratory, we found that a time period of 90 min 
between collection and analysis is just about real-
izable. In Germany, registered doctors’ surgeries 
and many hospitals are now relying on services 
from laboratories that are located at a considera-
ble distance. Thus, the required time of 90 min be-
tween sample collection and analysis is either dif-
ficult to achieve or not feasible.
Despite the fact that this is a well-known problem, 
very little attention is given to preanalytics. Yet, in 
the event of clinically implausible results, a possi-
ble preanalytical bias should definitely be consid-
ered. In the very common disease pattern of UTI, 
consequent adherence to correct preanalytics is 
problematic for clinicians. Also, there are no stand-
ardized reference ranges. Moreover, different cut-
off values currently exist. In a study with 438 sam-
ples analyzed with UF-100™ (Sysmex, Norderstedt, 
Germany), cut-off values for erythrocytes (RBC) 
were 30 RBC / µL and 41 WBC / µL (21). In a collec-
tive of 2010 samples, the cut-off was 25 cells / mL 
for evaluation of pyuria and 100,000 bacteria / mL 
for evaluation of bacteriuria (22). In a study with 
252 samples comparing automated analysis (UF-
100™) with urine microscopy, cut-offs were 26 WBC 
/ µL, 26 RBC / µL, 1.95 squamous epithelial cells / 
µL and 0.39 casts / µL (23). This highlights the 
problems in urinalysis and the risk of possible false 
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or delayed diagnosis resulting from the many po-
tential pitfalls. Since UTI is one of the most com-
mon bacterial infections, a large number of pa-
tients may receive a false diagnosis due to the fre-
quency of this disease (24). Urine dipstick analysis 
is applied as a simple screening tool and, normally, 
more elaborate examinations are carried out only 
in case of pathological findings. Our study shows 
that the time of analysis after sample collection 
plays a more important role than previously as-
sumed.
A recent study investigated whether uropatho-
gens are detectable with flow cytometry prior to 
culture analysis. The aim of that study was to ob-
tain precise, cost effective and rapid reliable re-
sults to confirm the very common tentative diag-
nosis of UTI (25). A weakness of the study was that 
the time of analysis was within three hours. A 
study design with an early time of analysis would 
have been more interesting since we were able to 
show a noticeable change in many parameters as 
early as 90 to 120 min from urine collection. An 
Italian multicenter study carried out a similar in-
vestigation. However, UF-1000i™ analysis was per-
formed within four hours after collection (26).
While no significant changes were found for bac-
teria within the time period of our study, the path-
ogen spectrum should be considered for clinical 
interpretation since in some samples we noted an 
increase and in other samples a decrease. It should 
also be investigated whether these correlate with 
the respective pathogen. The most common path-
ogens of an uncomplicated UTI in women are: Es-
cherichia coli, Enterococcus faecalis, Staphylococcus 
saprophyticus, Klebsiella pneumoniae and Proteus 
mirabilis (27). In the future, microbiologic analysis 
should be able to determine which bacteria are 
actually multiplying in the collected urine sample. 
To include as many pathological findings as possi-
ble, specification of criteria of automated urinaly-
sis is becoming more exact, aiming for the lowest 
possible missed diagnosis rate (28). In addition to 
the widespread use in the diagnosis of UTI, we also 
noted significant misclassifications rates over dif-
ferent time points of analysis regarding protein 
concentrations in the protein pad of the urine dip-
stick where mainly urine albumin is detected. The 
possible effects of false negative protein values for 
patients must be discussed since albuminuria/pro-
teinuria could, for instance, indicate a possible di-
agnosis of kidney damage (29).
Clinical routine and laboratory diagnosis are cru-
cial and in case of discordances, the analysis meth-
ods must be scrutinized and examined for poten-
tial sources of error to avoid erroneous therapy. 
The manufacturer’s instructions of the analysis 
systems that we used list a large number of poten-
tial interference factors, which can compromise 
the correct interpretation of the results. For exam-
ple, the erythrocyte pad result of the urine dipstick 
can be false positive due to contamination with 
menstrual blood or after strenuous physical exer-
cise. Ketones results can be falsified due to fever or 
fasting and leukocyte results can be distorted by 
vaginal secretion. 
In contrast to Veljkavic et al., who also highlighted 
the critical issue of the correct time point for urine 
analysis, our study shows that even earlier time 
points for analysis should be observed (11).
One limitation of our study was the fact that we 
did not examine the pathogen spectrum of the 
bacteria positive results and whether a correlation 
exists between the specific pathogen and an in-
crease / decrease in number of bacteria. Also, we 
used Urisys™ 2400 (Roche Diagnostics GmbH, Man-
nheim, Germany), an older model, which, while no 
longer produced, is still widely used for diagnosis 
in laboratories. The lack of universally valid refer-
ence ranges is a further problem. Thus, a laborato-
ry must establish its own reference ranges. This 
calls even more for exact adherence to preanalyt-
ics, as confirmed by our results. However, the de-
velopment of reference ranges can also be prob-
lematic since it requires a collective of healthy per-
sons who are not easy to find in the hospital set-
ting. Therefore, reference ranges for a large collec-
tive are urgently required for automated urine di-
agnoses. For the UF-1000i™, there are no German 
EQA programmes available.
The importance of correct analysis results be-
comes obvious when considering the broad range 
of medical problems where urinalysis plays a deci-
sive role. Ultimately, our study shows that the 
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longer the time period between urine sample col-
lection and analysis, the higher the probability of 
false interpretation due to instability of some pa-
rameters. This applies especially to physiological 
and pathological cell counts, which are decisive in 
further diagnosis. Our study stresses the impor-
tance of adherence to early time points in urinaly-
sis (within 90 min from collection). 
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